Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation
Authorsde Vries, H. M.
Lee, H. J.
Djajadiningrat, R. S.
Ottenhof, S. R.
Kroon, B. K.
de Jong, I. J.
Alnajjar, H. M.
Stuiver, M. M.
Brouwer, O. R.
AffiliationDepartment of Urology, Netherlands Cancer Institute, Amsterdam, Netherlands
MetadataShow full item record
AbstractObjective To develop a predictive model for additional inguinal lymph node metastases (LNM) at inguinal lymph node dissection (ILND) after positive dynamic sentinel node biopsy (DSNB) using DSNB characteristics to identify a patient group in which ILND might be omitted. Patients and Methods We conducted a retrospective study of 407 inguinal basins with a positive DSNB in penile cancer patients who underwent subsequent ILND from seven European centres. From the histopathology reports, the number of positive and negative lymph nodes, presence of extranodal extension and size of the metastasis were recorded. Using bootstrapped logistic regression, variables were selected for the clinical prediction model based on the optimization of Akaike's information criterion. The area under the curve (AUC) of the receiver-operating characteristic curve was calculated for the resulting model. Decision curve analysis (DCA) was used to evaluate the clinical utility of the model. Results Of the positive DSNBs, 64 (16%) harboured additional LNM at ILND. Number of positive nodes at positive DSNB (odds ratio [OR] 2.19, 95% confidence interval (CI) 1.17–4.00; P = 0.01) and largest metastasis size in mm (OR 1.06, 95% CI 1.03–1.10; P = 0.001) were selected for the clinical prediction model. The AUC was 0.67 (95% CI 0.60–0.74). The DCA showed no clinical benefit of using the clinical prediction model. Conclusion A small but clinically important group of basins harbour additional LNM at completion ILND after positive DSNB. While DSNB characteristics were associated with additional LNM, they did not improve the selection of basins in which ILND could be omitted. Thus, completion ILND remains necessary in all basins with a positive DSNB.
Citationde Vries HM, Lee HJ, Lam W, Djajadiningrat RS, Ottenhof SR, Roussel E, et al. Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation. BJU Int. 2021.
- Reliability of dynamic sentinel node biopsy combined with ultrasound-guided removal of sonographically suspicious lymph nodes as a diagnostic approach in patients with penile cancer with palpable inguinal lymph nodes.
- Authors: Naumann CM, van der Horst S, van der Horst C, Kähler KC, Seeger M, Osmonov D, Lützen U, Jünemann KP, Franz Hamann M
- Issue date: 2015 Sep
- Dynamic sentinel node biopsy for inguinal lymph node staging in patients with penile cancer: a systematic review and cumulative analysis of the literature.
- Authors: Neto AS, Tobias-Machado M, Ficarra V, Wroclawski ML, Amarante RD, Pompeo AC, Del Giglio A
- Issue date: 2011 Jul
- Management of the lymph nodes in penile cancer.
- Authors: Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H
- Issue date: 2010 Aug
- [Initial Experiences of Dynamic Sentinel Lymph Node Biopsy (DSNB) in Patients with Penile Cancer].
- Authors: Abe N, Hori JI, Kobayashi S, Kikuchi D, Tateoka J, Watanabe M, Wada N, Tamaki G, Kita M, Matsuya T, Ishida-Yamamoto A, Kakizaki H
- Issue date: 2020 Jul
- Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.
- Authors: Heyns CF, Theron PD
- Issue date: 2008 Aug